Development and Verification of an Immune-Based Gene Signature for Risk Stratification and Immunotherapeutic Efficacy Assessment in Gastric Cancer

Table 3

Clinical characteristics of patients in the high- and low-risk groups from the GSE66229 dataset.

Characteristics		High risk ()	Low risk ()	Total ()	value
Age	<65	87	74	161	0.1647
	≥65	63	76	139
Stage	Stage I	9	21	30	0.0073
	Stage II	40	56	96
	Stage III	55	40	95
	Stage IV	45	32	77
	NA	1	1	2
T	T2	75	111	186	<0.0001
	T3	60	31	91
	T4	14	7	21
	NA	1	1	2
M	M0	131	142	273	0.0437
	M1	19	8	27
N	N0	14	24	38	0.1309
	N1	62	69	131
	N2	47	33	80
	N3	27	24	51
Gender	Female	53	48	101	0.6251
	Male	97	102	199